Clinical Trial Update: An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of GSK1605786A in Crohn's disease was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• GSK1605786A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2017-08-17